Business
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News
A study finds treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces…
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been…
-
Noosa News17 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General16 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General23 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
General19 hours agoMan dies at shopping centre car park at Charlestown following reports of assault